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012.03.0Abstract Objectives: In recent years, fucoidan is being marketed as a nutraceutical and food sup-
plement because of its various pharmacological activity. Hence, we evaluated the cardioprotective
activity of fucoidan extracted fromTurbinaria conoides in isoproterenol induced myocardial injured
rats.
Methods: Wistar rats (180 ± 20 g) were divided into eight groups of six animals each and fucoidan
was administered orally in three different doses (50, 100 and 150 mg/kg), for 14 days. At the end of
this period, all the rats, except control group and fucoidan alone treated groups, were administered
isoproterenol for two consecutive days to induce myocardial injury. After 48 h, rats were anesthe-
tized, sacriﬁced and the levels of biochemical parameters were determined and histopathological
analysis carried out.
Results: Biochemical assessment of myocardial injury was done by measuring the activities of cre-
atine kinase and lactate dehydrogenase, which were signiﬁcantly elevated in the rats administered44 238343x223; fax: +91 4144
o.in (T. Manivasagam).
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148 K. Mohankumar et al.with isoproterenol. Further, pretreatment of fucoidan signiﬁcantly normalized both endo and exog-
enous antioxidant defense system in isoproterenol induced myocardial injured rats. Therefore, fuco-
idan considerably reduced oxidative stress. In addition, histopathological ﬁndings were in line with
biochemical ﬁndings.
Conclusion: As a consequence, fucoidan possesses cardioprotective and antioxidative effect against
isoproterenol induced myocardial injury in rats.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Cardiovascular diseases are the principal cause of mortality
worldwide. Reduction of mortality rate and prevention of
myocardial injury (MI) are of utmost importance. MI is the
condition of necrosis of the myocardium that occurs as a result
of imbalance between coronary blood supply and myocardial
demand.[1] Isoproterenol (ISO), a synthetic non-selective b-
adrenoceptor agonist, has been exceptionally known to induce
MI in rats as a result of disturbed physiological balance be-
tween production of free radicals and antioxidative defense
system.[2] In addition to these, the reduction of blood pressure
that is observed on administration of ISO, by means of periph-
eral vasodilatation is also suggested to cause MI.[3] Hence, we
have chosen the ISO model for this study. Therapeutic inter-
vention by means of suppressing free radical generation and/
or augmentation of endogenous antioxidant enzymes may lim-
it the infarct size and attenuate MI.[4]
MI is a devastating disease which badly needs a medical
breakthrough. Although modern drugs are effective in treating
this condition, they are mostly accompanied with adverse ef-
fects. Marine plants, especially seaweeds are a largely unex-
plored reservoir of bioactive compounds. Brown seaweeds
(Phaeophyceae) are known to produce different polysaccha-
rides, namely alginates, laminarans and fucoidans. Fucoidan
is a polyanionic sulfated polysaccharide mainly composed of
a-1,3 backbones or repeating disaccharide units of a-1,3 and
a-1,4 linked fucose residues with branching attached at C2
positions. Depending on the structure of the main chain, fucoi-
dans may be sulfated at C4, C2 or in both positions of the fu-
cose units.[5,6] Besides fucose, fucoidans may also contain
minor amounts of other sugars like xylose, galactose, mannose
and glucuronic acid.[7] It has been broadly studied in recent
years, because it is endorsed with important biological proper-
ties such as antioxidant,[8] anticoagulant, antithrombotic,[9]
antitumor,[10] and antiviral activities.[11] Additionally, fucoi-
dan administration has no adverse effects on rats.[12]
To the best of our knowledge, efﬁcacy of fucoidan of Tur-
binaria conoides (J. Agardh) in ISO induced MI and oxidative
stress related parameters have not been scientiﬁcally explored
till date. Therefore, the present study was designed to investi-
gate the effects of oral administration of fucoidan on ISO in-
duced MI in rats.
2. Material and methods
2.1. Animals
All the experiments were carried out with male albino Wistar
rats weighing 180–200 g, obtained from The Central Animal
House, Rajah Muthiah Institute of Health Sciences, Annama-lai University, Tamil Nadu, India. They were housed in poly-
propylene cages (47 cm · 34 cm · 20 cm) lined with husk,
renewed every 24 h under a 12:12 h light/dark cycle at around
22 C. The rats had free access to tap water and food. The rats
were fed standard pellet diet (Pranav Agro Industries Ltd.,
Maharashtra, India). The experiment was carried out accord-
ing to the guidelines of the Committee for the Purpose of Con-
trol and Supervision of Experiments on Animals (CPCSEA),
New Delhi, India, and approved by the Animal Ethics Com-
mittee of Annamalai University (Approval No. 809:
20.04.2011).
2.2. Collection and extraction of fucoidan
Fresh and healthy specimens of T. conoides, brown seaweeds,
belonging to the Phaeophyceae family were collected along
the coast of Tamil Nadu, India, during the year 2011. The spe-
cies were identiﬁed and authenticated by Phycologist Dr. P.
Anantharaman, Associate Professor, Centre for Advanced
Study in Marine Biology, Annamalai University, Parangipet-
tai, India. One voucher specimen was stored in our aquarium
for future reference. The collected alga was initially washed in
sea water to remove the macroscopic epiphytes and other
extraneous matter and then rinsed in distilled water. The spec-
imen was shade dried and coarsely powdered. Brieﬂy 200 g of
the dried seaweed powder was depigmented with acetone for
24 h followed by hot water extraction at 90–95 C for 3–4 h.
The brown colored syrup was then ﬁltered through Whatman
no. 4 ﬁlter paper, concentrated to 1/4th of the original volume,
cooled and precipitated with three volumes of ethanol over-
night at 4 C. The precipitate was collected by centrifugation
and dehydrated with diethyl ether to get a dried sulfated poly-
saccharide, fucoidan. The chemical composition of the ex-
tracted fucoidan is carbohydrates 57.62%, uronic acid 7.2%,
and sulfate 21.12%. ISO was purchased from Sigma Chemical
Company (St. Louis, MO) and all the other chemicals used
were of analytical grade.
2.3. Induction of experimental myocardial injury
ISO (100 mg/kg) was dissolved in saline and subcutaneously
injected to male albino Wistar rats at an interval of 24 h for
2 days. MI was conﬁrmed by elevated activity of serum crea-
tine kinase (CK) in rats.
2.4. Experimental design
In this experiment, a total of 48 male albino Wistar rats were
randomly divided into eight groups of six rats each as follows:
 Group I: Normal control rats.
igure 1 Effect of fucoidan on cardiac markers. Group I:
ormal control, Group II: Fucoidan (50 mg/kg) alone, Group III:
ucoidan (100 mg/kg) alone, Group IV: Fucoidan (150 mg/kg)
lone, Group V: ISO control (100 mg/kg), Group VI: Fucoidan
50 mg/kg) + ISO (100 mg/kg), Group VII: Fucoidan (100 mg/kg)
ISO (100 mg/kg), Group VIII: Fucoidan (150 mg/kg) + ISO
100 mg/kg). Each column is mean ± S.D. for six rats in each
roup. Signiﬁcance was determined by a one-way ANOVA
ollowed by Tukey’s test. *P< 0.05 versus normal control.
P< 0.05 versus ISO control. **Units: CK activity is expressed
s lM of phosphorus generated/min/mg protein and LDH activity
expressed as nM of pyruvate liberated/min/mg protein.
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100, and 150 mg/kg, respectively) alone daily for 14 days
using an intra gastric tube.
 Group V: Rats were subcutaneously injected with ISO
alone (100 mg/kg) at an interval of 24 h for 2 days (on
15th and 16th days).
 Group VI–VIII: Rats were pretreated with fucoidan (50,
100 and 150 mg/kg, respectively) daily for 14 days and then
subcutaneously injected with ISO (100 mg/kg) for 2 days
(on 15th and 16th days).
At the end of the experimental period, after 12 h of second
ISO injection, (i.e. on 16th day) all the rats were anesthetized
and then sacriﬁced by cervical decapitation. Blood was col-
lected and subsequently plasma and serum were separated by
centrifugation. The heart tissue was excised immediately from
the animals, washed off blood with ice-chilled physiological
saline and stored for further biochemical estimations. A
known weight of the heart tissue was homogenized in 5 ml
of 0.1 M Tris–HCl (pH 7.4) buffer solution. The homogenate
was centrifuged at 3000 rpm for 5 min and the supernatant
was used for the estimation of various biochemical parameters.
2.5. Assay of cardiac marker enzymes
Activities of CK and lactate dehydrogenase (LDH) were mea-
sured in the heart tissue homogenate by standard commercial
kits. LDH isoenzymes were separated by agarose gel
electrophoresis.[13]
2.6. Assay of antioxidants
The activities of superoxide dismutase (SOD), catalase, glutathi-
one peroxidase (GPx), and glutathione reductase (GRx) in the
heart tissue homogenate were assayed.[14–17] The levels of vita-
min C, vitamin E and reduced glutathione (GSH) in the plasma
and heart tissue homogenate were also estimated.[18–20] The
content of protein in the heart tissue homogenate was also
determined.[21]
2.7. Histopathology of myocardium
The heart tissues obtained fromall the groupswerewashed immedi-
ately with saline and then ﬁxed in 10% buffered neutral formalin
solution.After ﬁxation, the heart tissues were processed and embed-
ded in parafﬁn. Then, the heart tissues were sectioned and stained
with hematoxylin and eosin and examined under a high power
microscope (100·), and photomicrographs were taken.
2.8. Statistical analysis
Statistical analysis was performed by a one-way analysis of
variance followed by Tukey’s test using Statistical Package
for the Social Science (SPSS) software package version 12.0.
Results were expressed as mean ± SD for six rats in each
group. P values <0.05 were considered signiﬁcant.
3. Results
Fig. 1 represents the effect of fucoidan on the activities of heart
CK and LDH in normal and ISO induced rats. Rats inducedwith ISO showed a signiﬁcant (P< 0.05) decrease in the activ-
ities of these marker enzymes in heart compared to normal
control rats. Prior treatment with fucoidan daily for a period
of 14 days signiﬁcantly (P< 0.05) protects the decline of the
activities of these enzymes in the heart of ISO induced rats
compared with ISO alone induced rats. Agarose gel electro-
phoretic separation of serum LDH isoenzyme patterns of nor-
mal and ISO induced rats is illustrated in Fig. 2. Normal
control and fucoidan alone induced rats did not show any in-
crease in the intensities of serum LDH 1 and 2 isoenzyme pat-
terns. ISO induced rats showed increased intensities of LDH 1
and 2 isoenzyme bands compared to normal control rats. Pre-
treatment with fucoidan (150 mg/kg) normalized the intensities
of LDH 1 and 2 isoenzyme bands in ISO induced rats com-
pared with ISO alone induced rats.
In our results, a signiﬁcant (P< 0.05) decrease in activities
of SOD, catalase, GPx and GRx in the heart tissue homoge-
nate in ISO induced rats compared to normal control rats
was observed. Pretreatment with fucoidan normalized
(P< 0.05) the activities of enzymic antioxidants in ISO in-
duced rats compared to ISO alone treated rats (Fig. 3). ISO in-
duced rats exhibited signiﬁcant (P< 0.05) decrease in levels of
vitamin C, vitamin E and GSH in the plasma and heart tissue
homogenate compared to normal control rats. Pretreatment
with fucoidan normalized (P< 0.05) the levels of vitamin C,
vitamin E and GSH in the plasma and heart tissue homogenate
in ISO induced rats compared to ISO alone treated rats
(Table 1).
Histopathological ﬁndings of the normal control rats heart
showed normal cardiac muscle ﬁbers (Fig. 4a), and normal rats
heart induced with fucoidan showed normal cardiac ﬁbers
without any notable damages (Fig. 4b). However, the ISO in-
duced myocardium showed diffuse inﬂammatory inﬁltrate in
between muscle bundles (Fig. 4c), mononuclear collections












Figure 2 Effect of fucoidan on serum lactate dehydrogenase
isoenzyme pattern. Group I: Normal control, Group IV: Fucoidan
(150 mg/kg) alone, Group V: ISO control (100 mg/kg), Group
VIII: Fucoidan (150 mg/kg) + ISO (100 mg/kg).
Figure 3 Effect of fucoidan on enzymatic antioxidants. Group I:
Normal control, Group II: Fucoidan (50 mg/kg) alone, Group III:
Fucoidan (100 mg/kg) alone, Group IV: Fucoidan (150 mg/kg)
alone, Group V: ISO control (100 mg/kg), Group VI: Fucoidan
(50 mg/kg) + ISO (100 mg/kg), Group VII: Fucoidan (100 mg/kg)
+ ISO (100 mg/kg), Group VIII: Fucoidan (150 mg/kg) + ISO
(100 mg/kg). Signiﬁcance was determined by a one-way ANOVA
followed by Tukey’s test. *P< 0.05 versus normal control.
#P< 0.05 versus ISO control. **Units: SOD: U/mg protein.
SOD: one unit is deﬁned as the enzyme concentration required
inhibiting the OD at 560 nm of chromogen production by 50% in
1 min, Catalase: lM of H2O2 consumed/min/mg protein, GPx: lg
of GSH consumed/min/mg protein and GRx: nM of NADPH
oxidized/min/100 mg protein.
150 K. Mohankumar et al.Fig. 4d showed normal cardiac ﬁbers without notable damages
in rat’s heart pretreated with fucoidan in ISO induced rats. Ta-
ble 2 illustrates the effects of fucoidan on the degree of histo-
logical changes in the heart of normal and ISO induced
myocardial injured rats. Normal control rats and normal rats
treated with fucoidan showed normal cardiac muscle ﬁberswithout any notable changes (). ISO induced rats showed dif-
fuse inﬂammatory inﬁltrate (+++), mononuclear collections
(+++), broken cardiac ﬁbers (+++) and hemorrhage
(+++). Pretreatment with fucoidan in ISO induced rats
showed normal cardiac ﬁbers without hemorrhage (), broken
cardiac ﬁbers () mononuclear collections () and diffuse
inﬂammatory inﬁltrate (). Fucoidan pretreatment (150 mg/
kg) to ISO induced rats showed a signiﬁcant effect on all the
biochemical parameters studied. There was no considerable
change in the normal control rats treated with fucoidan
(150 mg/kg) daily for a period of 14 days.
4. Discussion
There is a huge global demand for safe and effective natural
nutraceutical ingredients that can provide preventative health
beneﬁts. In recent years, extensive pharmaceutical researches
have been done on fucoidan, as a result, it is now being mar-
keted as a nutraceutical and food supplement.[22] In our
experiment, we found that fucoidan of T. conoides protected
the myocardium from ISO induced myocardial functional
and structural injury via favorably maintained biochemical,
electrophoretic and histopathological parameters suggesting
its cardioprotective action.
In our study, we observed decreased activities of cardiac
marker enzymes such as CK and LDH in the myocardium.
Myocardial cells containing these enzymes are damaged or de-
stroyed due to insufﬁcient oxygen and glucose supply and the
cell membrane becomes permeable or may rupture, which re-
sults in the leakage of these enzymes. This action may be
due to the damage caused to the sarcolemma by ISO rendering
it leaky.[23] This accounts for the decreased activities of these
enzymes in the heart of ISO induced MI in rats. Pretreatment
with fucoidan normalized the activities of these enzymes by
their antioxidant activity,[8] which may explain their ability
to protect the myocardium from damage by preventing the
leakage of these enzymes from the heart. LDH isoenzymes ex-
ist in ﬁve different isoforms (LDH 1–LDH 5). In cardiac tis-
sue, LDH 1 and LDH 2 are predominant, so the detection
of elevated concentrations of this enzyme in serum has become
a deﬁnitive diagnostic and prognostic criterion for various dis-
eases and studies of its isoenzymes have found importance in
the location of tissue damage.[24] It can be differentiated from
other types of tissue damage, because LDH isoenzymes begins
to rise in 12–24 h following MI and peaks in 2–3 days then
gradually dissipating in 5–14 days.[25] The increased abun-
dance of serum LDH 1 and LDH 2 bands in ISO induced rats
observed in this study could be due to ISO induced cardiac in-
jury, which is supported by previous report.[26] Normalization
of the intensities of LDH 1 and LDH 2 bands in ISO induced
rats by pretreatment with fucoidan (150 mg/kg) might proba-
bly be due to its free radical scavenging potential, thereby sug-
gesting good antioxidant activity.[8]
We further studied the underlying mechanisms of fucoidan
in ISO induced rats. Pharmacological augmentation of endog-
enous myocardial antioxidants such as SOD, catalase, GPx,
and GRx has been identiﬁed as a promising therapeutic ap-
proach in diseases associated with increased oxidative stress,
i.e., the ﬁrst line of cellular defense against oxidative stress.
The observed decreased activities of SOD and catalase in
ISO induced cardiac tissue might be due to O2 generated at
Table 1 Effect of fucoidan on the levels of non-enzymatic antioxidants in normal and ISO induced myocardial injured rats.
Groups Plasma (mg/dl) Heart (mM/mg protein) Heart GSH (mM/g wet tissue)
Vitamin C Vitamin E GSH Vitamin C Vitamin E
Normal control 3.54±0.3 2.06±0.11 30.13±2.4 1.81±0.1 0.7±0.05 8.49±0.7
Fucoidan (50 mg/kg) 3.51±0.3 1.85±0.12 29.56±2.4 1.79±0.1 0.69±0.05 8.41±0.7
Fucoidan (100 mg/kg) 3.55±0.3 1.96±0.12 30.25±2.4 1.82±0.1 0.72±0.05 8.59±0.7
Fucoidan (150 mg/kg) 3.61±0.3 1.99±0.12 30.82±2.5 1.85±0.1 0.74±0.05 8.67±0.7
ISO (100 mg/kg) 1.02±0.09a 0.96± 0.06a 14.96±1.2a 1.05±0.1a 0.33±0.04a 4.52±0.4a
Fucoidan (50 mg/kg) + ISO (100 mg/kg) 1.85±0.1b 1.25±0.12b 19.56±1.2b 1.25±0.1b 0.39±0.04b 5.25±0.4b
Fucoidan (100 mg/kg) + ISO (100 mg/kg) 2.65±0.1b 1.56±0.12b 24.35±1.7b 1.65±0.1b 0.53±0.05b 6.96±0.7b
Fucoidan (150 mg/kg) + ISO (100 mg/kg) 3.3±0.2b 1.85±0.12b 29.27±1.8b 1.77±0.1b 0.65±0.05b 8.32±0.7b
Each column is mean ± S.D. for six rats in each group. Signiﬁcance was determined by a one-way ANOVA followed by Tukey’s test.
a P< 0.05 versus normal control.
b P< 0.05 versus ISO control.
Figure 4 Histopathological changes of myocardium. Scale bar in a = 100 lm in all (heamatoxylin and eosin (HE) staining 100·). (a)
Normal untreated rats showing normal cardiac muscle ﬁbers (Group I). (b) Fucoidan (150 mg/kg) alone treated rats showing the normal
cardiac ﬁbers without any notable damages (Group IV). (c) Isoproterenol induced myocardium showing diffuse inﬂammatory inﬁltrate in
between muscle bundles (Group V). (c1) Isoproterenol induced myocardium showing mononuclear collections (Group V). (c2)
Isoproterenol induced myocardium showing hemorrhage and broken cardiac ﬁbers (Group V). (d) Fucoidan (150 mg/kg)
pretreated + isoproterenol (100 mg/kg) induced rats showing the normal cardiac ﬁbers without any notable damages (Group VIII).
Sulfated polysaccharides of Turbinaria conoides dose-dependently mitigate 151the site of damage, which modulates SOD and catalase result-
ing in decreased activities and leads to the accumulation of the
O2 , which damages the myocardium.[27] Pretreatment with
fucoidan normalized the activities of these enzymes in ISO in-duced rats. Accordingly, fucoidan scavenges O2 and reduces
myocardial injury caused by free radicals in the myocardium
due to ISO treatment. The glutathione dependent enzymes
GPx and GRx are lowered in ISO induced cardiac tissue.
Table 2 Effects of fucoidan on the degree of histopathological changes in normal and ISO induced myocardial injured rats.
Groups Diﬀuse inﬂammatory inﬁltrate Mononuclear collections Hemorrhage Broken cardiac ﬁbres
Normal control    
Fucoidan (150 mg/kg)    
ISO (100 mg/kg) + + + + + + + + + + + +
Fucoidan (150 mg/kg) + ISO (100 mg/kg)    
Photomicrographs were used to evaluate the degree of damage in the heart tissues: () no changes. (+ + +) marked changes.
152 K. Mohankumar et al.The decreased activity of these enzymes in ISO induced rats is
due to the decreased concentration of their substrate, GSH.[28]
The enhanced protective mechanism toward oxidative stress in
MI may consume GSH and depress GSH levels. The observed
decrease in GSH might also be due to increased utilization in
protecting thiol containing proteins from lipid peroxides and
from other reactive oxygen species. Prior treatment with fuco-
idan normalized the activities of GSH dependent enzymes and
the levels of GSH in ISO induced rats. Cellular injury can be
prevented by increasing intracellular GSH. The enhanced con-
centration of GSH observed in fucoidan pretreated ISO in-
duced rats resulting in the enhanced activities of GSH
related enzymes and thus prevents cellular injury in myocar-
dium. The antioxidant effect of fucoidan is clearly revealed
by this effect.
The second line of cellular defense against oxidative stress
consists of the non-enzymatic scavengers namely, vitamin C,
vitamin E, ceruloplasmin and sulfhydryl containing com-
pounds, which scavenge the residual free radicals escaping
from decomposition by the antioxidant enzymes. An inverse
correlation exists between plasma levels of vitamin E and mor-
tality from MI.[29] The lowered concentrations of vitamins C
and E observed in ISO induced rats might be due to neutraliz-
ing increased production of free radicals. Prior treatment with
fucoidan normalized the levels of these vitamins in ISO in-
duced rats. The retained concentration of these vitamins may
protect the heart against ISO mediated free radicals in the
fucoidan pretreated ISO induced group.
Histopathological ﬁndings of the myocardial injured rat’s
heart pretreated with fucoidan (150 mg/kg) showed a well pre-
served normal morphology of cardiac muscle without notable
changes compared to ISO induced rat’s heart. Thus, fucoidan
protected the myocardium against injury caused by ISO and
inhibited lipid peroxidation and thus protected the near nor-
mal architecture of the myocardium.
5. Conclusion
Oral administration of fucoidan (150 mg/kg) extracted from
brown seaweeds, T. conoides signiﬁcantly protects the myocar-
dium by maintaining the biochemical, electrophoretic and his-
topathological parameters against ISO induced myocardial
injury. These effects could be due to its antioxidant and mem-
brane stabilizing properties. The results of this present investi-
gation may trigger a renewed interest in the use of T. conoides
fucoidan for MI.References
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